ERICA ORTIZ: Open Payments
NPI 1942947593 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 21 payments from 8 companies in 2025. Trend: 2023 $314 · 2024 $322 · 2025 $735
Food & beverage: $635Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $225 |
| Sumitomo Pharma America, Inc. | 8 | $181 |
| Boston Scientific Corporation | 1 | $134 |
| UROGEN PHARMA, INC. | 4 | $67 |
| Ferring Pharmaceuticals Inc. | 2 | $50 |
| Janssen Biotech, Inc. | 2 | $46 |
| Endo USA, Inc. | 1 | $16 |
| COLOPLAST CORP | 1 | $16 |
Products named: GEMTESA, Axonics, Xtandi, JELMYTO, ADSTILADRIN, ERLEADA, XIAFLEX, Luja Coude.
Industry payments across TX — which companies pay providers there.
